Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples